Skip to main content

Table 4 Seroprevalence of HCV in the two regions.

From: Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands

 

Number in methadone care

HCV screening

N (%)

HCV prevalence

N (%)

Amsterdam*

2566

1359 (53%)

350 (26%)

- starting treatment1

  

53 (15%)

Heerlen**

287

190 (66%)

115 (61%)

- starting treatment

  

55 (48%)

  1. 1Obtained from the Dutch-C project of the public health centre in Amsterdam within the Amsterdam Cohort Studies among drug users, * Data of 2004-2008, ** Data of 2003-2008
Back to article page

Harm Reduction Journal

ISSN: 1477-7517